A Multicenter Phase II Study of Modified FOLFIRINOX for First-line Treatment for Advanced Urachal Cancer (ULTMA; KCSG GU20-03)
{{output}}
Purpose: To assess the efficacy and safety of the first-line modified FOLFIRINOX in patients with advanced urachal cancer. Materials and methods: ... ...
